This Digital Health News industry roundup covers Maven Clinic’s acquisition of Naytal and Medwise.ai securing a £1 million investment to scale up operations.
max20 Project Solutions plans national expansion
max20 Project Solutions, a North West business which delivers digital transformation projects to the NHS, is planning to expand nationwide.
The business has completed over £50 million worth of projects since its launch six years ago and increased turnover by an average of over 50% each year during that time. It is now the leading provider of digital services through the NHS GCloud supplier framework which serves around 300 NHS bodies.
Although it mainly operates in the North West and Wales, it now plans to roll its services throughout the UK to help the NHS to take advantage of the opportunities offered by digital technologies.
Don Tomlinson, managing director at max20 Project Solutions, said: “The NHS is facing its biggest challenges in years, yet digital technologies offer the opportunity to dramatically improve efficiency and transform outcomes for patients.
“As a specialist in healthcare technology we can draw on our vast network of subject matter experts to mobilise quickly and effectively. Our key differentiators see us well placed to scale our model and expand across the UK, whilst understanding the challenges and constraints facing the NHS.”
Maven Clinic accelerates growth in UK with acquisition of Naytal
Maven Clinic, the world’s largest virtual clinic for women’s and family health, has announced that it has acquired the London-based digital health company Naytal to accelerate its expansion in the UK and throughout Europe.
The acquisition of Naytal will immediately enhance Maven’s ability to serve its growing membership in the UK and deliver on its promise of providing every family, everywhere, with access to high-quality personalised care.
Kate Ryder, founder and CEO of Maven Clinic, said: “Maven’s digital platform has been built to address gaps in reproductive and maternal health globally and meet each member, no matter where they are in the world, with the same level of high-quality, personalised care.
“With our acquisition of Naytal, our rapidly expanding UK and European membership will have even greater access to timely support that meets their unique needs through a partner deeply embedded in the region.”
Founded in 2021 by entrepreneur Leila Thabet, Naytal provides on-demand access to women’s and family health experts to support a broad range of reproductive healthcare needs, from fertility and pregnancy to postpartum care and menopause.
Naytal was the first platform in the UK to offer on-demand access to dedicated perinatal psychologists, and has since expanded its healthcare provider network to more than 25 specialties.
Founder and CEO Thabet said: “Maven has set the standard and paved the way for innovation for women’s and family healthcare globally and was an inspiration for me when I started Naytal.
“I am thrilled to be joining Kate and the team on their mission to provide better access to quality healthcare for women and families in the UK and throughout Europe.
Brainomix receives FDA clearance for its flagship stroke AI imaging software
Brainomix, the AI-powered medtech solutions company, has revealed that its Brainomix 360 e-ASPECTS tool for stroke has received FDA clearance, enabling it to deploy its cutting-edge stroke AI imaging platform to US stroke centres.
The Brainomix 360 stroke platform is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing patients to be treated in the right place, at the right time.
Powered by explainable AI, the Brainomix 360 e-ASPECTS tool assesses non-contrast CT scans to automatically generate an ASPECTS score and features a unique overlaid heatmap to visually assist clinicians to assess the output.
Dr Michalis Papadakis, CEO and co-founder of Brainomix, said: “We are delighted to have the opportunity to now take our technology to the US, where more than 800,000 patients suffer a stroke each year.
“Our e-ASPECTS tool has been shown, in multiple countries and healthcare systems, to improve physicians’ interpretations of ASPECTS scores on non-contrast CT scans – which carries particular clinical value for primary stroke centres, where there may not be around-the-clock specialist expertise, but where most stroke patients are first admitted.
“Our technology supports these physicians who are making time-sensitive, critical decisions around transfer and treatment, strengthening networks and facilitating an improved stroke service.”
Medwise.ai secures £1m investment to scale up operations
Digital health and artificial intelligence (AI) business Medwise.ai has secured a £1 million investment from Finance Yorkshire and other investors to scale up operations and strengthen its sales and marketing activities in the UK.
Medwise.ai is a search platform for medical professionals and healthcare organisations which significantly reduces the time clinicians spend looking up information during consultations, enabling them to see more patients and improve care quality.
Finance Yorkshire is investing £400,000 from its Seedcorn Fund and led the overall funding round of more than £1m, with participation from health-tech investors StartUp Health and CalmStorm VC and deep-tech accelerator and venture capital fund Deeptech Labs.
Medwise.ai also has the backing of clinician investors Dr Michelle Tempest at Candesic and Dr Chris Kelly at Google Health. SFC Capital has made a follow-on investment after leading a previous round of funding for Medwise.ai.
Dr Keith Tsui, chief executive and co-founder of Medwise.ai, said: “I am thrilled to have secured our seed funding and excited to accelerate our mission to empower clinicians with AI and search technologies.
“Our product provides clinicians with one search for clinical knowledge and local guidelines. Instead of Googling or going through outdated local websites or intranets, Medwise.ai enables clinicians to find the information they need to make decisions for patients rapidly at the point of care.”